Immunocore Holdings plc reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was GBP 143.74 million compared to GBP 26.52 million a year ago. Net loss was GBP 41.22 million compared to GBP 131.52 million a year ago.

Basic loss per share from continuing operations was GBP 0.9 compared to GBP 3.1 a year ago.